{"id":"https://openalex.org/W2564642986","doi":"https://doi.org/10.1182/blood.v124.21.4683.4683","title":"Inhibition of Wnt Signaling By Dimethyl Fumarate Results in in Vitro and in Vivo Clearance of Chronic Lymphocytic Leukemia Cells and Has Additive Activity with Ibrutinib","display_name":"Inhibition of Wnt Signaling By Dimethyl Fumarate Results in in Vitro and in Vivo Clearance of Chronic Lymphocytic Leukemia Cells and Has Additive Activity with Ibrutinib","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2564642986","doi":"https://doi.org/10.1182/blood.v124.21.4683.4683","mag":"2564642986"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.4683.4683","doi":"https://doi.org/10.1182/blood.v124.21.4683.4683","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.4683.4683","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061349962","display_name":"Christina C. N. Wu","orcid":"https://orcid.org/0000-0001-6369-6189","observed_orcids":["https://orcid.org/0000-0001-6369-6189"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina C.N. Wu","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018262832","display_name":"Fitzgerald S. Lao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fitzgerald Lao","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100719244","display_name":"Hongying Li","orcid":"https://orcid.org/0009-0001-1062-8438","observed_orcids":["https://orcid.org/0009-0001-1062-8438"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongying Li","raw_affiliation_strings":["University of California San Diego Moores Cancer Center, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego Moores Cancer Center, La Jolla, CA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010336471","display_name":"Laura Z. Rassenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Rassenti","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072839298","display_name":"Karen S. Messer","orcid":"https://orcid.org/0000-0002-9298-2413","observed_orcids":["https://orcid.org/0000-0002-9298-2413"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Messer","raw_affiliation_strings":["University of California San Diego Moores Cancer Center, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego Moores Cancer Center, La Jolla, CA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086448751","display_name":"Dennis Anthony Carson","orcid":"https://orcid.org/0000-0001-5273-0804","observed_orcids":["https://orcid.org/0000-0001-5273-0804"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis A. Carson","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075436982","display_name":"Michael Y. Choi","orcid":"https://orcid.org/0000-0002-9107-2186","observed_orcids":["https://orcid.org/0000-0002-9107-2186"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Y. Choi","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.3127,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.62234605,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"124","issue":"21","first_page":"4683","last_page":"4683"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dimethyl-fumarate","display_name":"dimethyl fumarate","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9399999976158142},{"id":"https://openalex.org/keywords/wnt-signaling","display_name":"Wnt signaling","score":0.8360000252723694},{"id":"https://openalex.org/keywords/lef1","display_name":"LEF1","score":0.7429999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.597000002861023},{"id":"https://openalex.org/keywords/cysteine-alkylation","display_name":"cysteine alkylation","score":0.6399999856948853},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.625},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6940000057220459},{"id":"https://openalex.org/keywords/oral-small-molecule-therapy","display_name":"oral small-molecule therapy","score":0.39100000262260437},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.5559999942779541},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9736477732658386},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.6648228168487549},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6497396230697632},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.564906120300293},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.553203821182251},{"id":"https://openalex.org/C2776819417","wikidata":"https://www.wikidata.org/wiki/Q418123","display_name":"Dimethyl fumarate","level":3,"score":0.50485759973526},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4203934669494629},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4039456844329834},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3805880546569824},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.371743381023407},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35954248905181885},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3425953984260559},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15325573086738586},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.0977482795715332},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.4683.4683","doi":"https://doi.org/10.1182/blood.v124.21.4683.4683","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.4683.4683","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2551577401","https://openalex.org/W4392925327","https://openalex.org/W2588928862","https://openalex.org/W2336296285","https://openalex.org/W2783191314","https://openalex.org/W2612940040","https://openalex.org/W2974158004","https://openalex.org/W1957142224","https://openalex.org/W3093432146","https://openalex.org/W2580812481"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Small":[2],"molecules":[3],"that":[4,37,58,241,420],"inhibit":[5,38],"B":[6],"cell":[7,322,408],"survival":[8,41],"pathways":[9,42],"are":[10,23,444,488,491],"effective":[11,469],"treatments":[12],"for":[13,45,80,372,459],"patients":[14,187,298],"with":[15,35,85,99,188,208,244,299,360,428],"chronic":[16],"lymphocytic":[17],"leukemia":[18],"(CLL).":[19],"However,":[20],"such":[21],"therapies":[22,34,82],"not":[24],"curative,":[25],"and":[26,49,68,74,148,162,190,229,234,302,313,399,451,465,478,490,500,509],"resistance":[27],"can":[28,242],"develop":[29],"in":[30,66,133,183,198,248,264,282,316,343,376,402,475,486],"some":[31],"patients.":[32],"Combination":[33],"agents":[36,86],"several":[39],"CLL":[40,67,185,210,295,321,346,362,381,407,424,487,512],"may":[43],"allow":[44],"more":[46,468],"complete":[47],"responses,":[48],"help":[50],"prevent":[51],"treatment":[52,116,458],"resistance.":[53],"Previous":[54],"data":[55],"has":[56,110,452],"shown":[57],"the":[59,105,154,249,283,341,391,395,511],"pro-survival":[60],"Wnt":[61,155,165,279,449],"pathway":[62],"is":[63,69,76,92,467,479,495],"highly":[64],"active":[65],"a":[70,114,141,170,259,317,344,403,457,498],"negative":[71],"prognostic":[72],"factor,":[73],"therefore":[75],"an":[77,93,237],"attractive":[78],"target":[79],"novel":[81,142],"to":[83,220,293,356,368,384,390,522],"combine":[84],"like":[87],"ibrutinib.":[88],"Dimethyl":[89],"fumarate":[90],"(DMF)":[91],"orally":[94],"bioavailable":[95],"fumaric":[96],"acid":[97],"ester":[98],"immunomodulatory":[100],"properties,":[101],"including":[102],"inhibition":[103,152],"of":[104,117,130,144,146,153,160,311,320,380,397,406,426,439,463,484,505,520],"NF-kB":[106],"signaling":[107,156,166,280],"cascade.":[108],"DMF":[109,147,161,215,233,266,290,312,352,398,421,447,464,485],"been":[111],"evaluated":[112,197],"as":[113,119,121,431,456],"systemic":[115],"psoriasis":[118],"well":[120,480],"multiple":[122,334],"sclerosis.":[123],"Our":[124],"group":[125],"previously":[126],"observed":[127],"anti-CLL":[128],"effects":[129],"DMF,":[131],"mediated":[132,150],"part":[134],"through":[135],"oxidative":[136],"stress.":[137],"Herein":[138],"we":[139,350],"describe":[140],"mechanism":[143],"action":[145],"ibrutinib,":[149],"by":[151,212,222,258,326,353,412,433,497,510],"pathway.":[157],"Methods:":[158],"Effects":[159],"ibrutinib":[163,217,235,314,400,466],"on":[164],"were":[167,206,218],"determined":[168],"using":[169],"cell-based":[171,260],"LEF/TCF":[172,268],"beta-lactamase":[173],"reporter":[174,261],"gene":[175,262,270],"FRET":[176],"assay.":[177,285],"In":[178,193,286],"vitro":[179],"activity":[180,195,281,455],"was":[181,196,256,291],"assessed":[182,432],"primary":[184,294],"from":[186,297,366],"indolent":[189,301],"aggressive":[191,303,429,476],"disease.":[192],"vivo":[194],"Rag2-/-":[199],"gamma":[200],"chain-/-":[201],"immunodeficient":[202],"(RG-KO)":[203],"mice,":[204],"which":[205,265],"engrafted":[207,359],"human":[209,361],"cells":[211,296,382,427],"intraperitoneal":[213],"injection.":[214],"and/or":[216],"administrated":[219],"mice":[221,358],"oral":[223,354],"gavage,":[224],"at":[225,272,305],"clinically":[226],"used":[227],"doses":[228],"schedules.":[230],"Results:":[231],"Both":[232],"have":[236],"alpha-beta":[238],"unsaturated":[239],"ketone":[240],"react":[243],"essential":[245],"free":[246],"cysteines":[247],"Wnt-driven":[250],"LEF1":[251],"transcription":[252],"factor.":[253],"This":[254,493],"effect":[255,342],"confirmed":[257],"assay":[263],"inhibited":[267,278],"dependent":[269,378],"expression":[271],"low":[273,306],"\u03bcM":[274],"levels.":[275],"Ibrutinib":[276],"also":[277],"same":[284],"short":[287],"term":[288],"cultures,":[289],"cytotoxic":[292],"both":[300],"disease,":[304,477],"uM":[307],"concentrations.":[308],"The":[309,461],"combination":[310,396,462],"resulted":[315,375,401],"higher":[318,404],"degree":[319,405],"clearance":[323,379,409],"than":[324,410,470],"achieved":[325,411],"either":[327,413,471],"agent":[328,414,454,472],"alone":[329],"(p":[330],"<":[331],"0.05":[332],"after":[333],"comparison":[335],"adjustments,":[336],"Dunnet\u2019s":[337],"method).":[338],"To":[339],"evaluate":[340],"preclinical":[345],"xenograft":[347],"animal":[348],"model,":[349],"administered":[351],"lavage":[355],"RG-KO":[357],"cells.":[363],"Doses":[364],"ranging":[365],"3":[367],"30":[369],"mg/kg":[370],"BID":[371],"7":[373],"days":[374],"dose":[377],"compared":[383],"vehicle":[385],"controls,":[386],"without":[387],"observable":[388],"toxicity":[389],"recipient":[392],"animals.":[393],"Moreover,":[394],"alone.":[415],"Preliminary":[416],"FACS":[417],"analyses":[418,438],"revealed":[419],"selectively":[422],"targets":[423],"subpopulations":[425],"characteristics,":[430],"CD38":[434],"expression.":[435],"Further":[436],"molecular":[437],"predictive":[440],"or":[441],"correlative":[442],"biomarkers":[443],"ongoing.":[445],"Conclusions:":[446],"inhibits":[448],"signaling,":[450],"single":[453],"CLL.":[460],"alone,":[473],"particularly":[474],"tolerated.":[481],"Clinical":[482],"trials":[483],"warranted,":[489],"planned.":[492],"work":[494],"supported":[496],"Leukemia":[499],"Lymphoma":[501],"Society":[502],"Specialized":[503],"Center":[504],"Research":[506,513],"Grant":[507],"(7005-14)":[508],"Consortium":[514],"(5P01CA081534-14).":[515],"Disclosures":[516],"No":[517],"relevant":[518],"conflicts":[519],"interest":[521],"declare.":[523]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}